Anti-SARS-CoV-2 Spike mAb (CR3022) is a human monoclonal IgG1 antibody derived from CHO cells. It specifically targets the S1 domain of the Spike protein in both SARS-CoV and SARS-CoV-2.
Anti-Spike-RBD mAb is a CHO cell derived human monoclonal IgG1 antibody. Blocking the interaction of spike protein and ACE2 is a potential therapeutic approach for SARS-CoV-2 treatment[1]. [1]. Chunyan Wang, et al. A Human Monoclonal Antibody Blocking SARS-CoV-2 Infection. Nat Commun. 2020 May 4;11(1):2251.
The Anti-Spike-RBD Single Domain mAb is a monoclonal antibody derived from CHO cells in Alpaca. It is composed of VHH-huFc and exhibits a strong affinity for the SARS-CoV-2 RBD. [1]
COVID-19 Spike Protein mRNA-LNP 是一种RNA传递系统,利用脂质纳米粒(LNP)封装COVID-19 Spike Protein mRNA,提高翻译效率与细胞活性。COVID-19 Spike Protein,位于新冠病毒膜表面,负责与宿主细胞受体结合和膜融合,是病毒进入细胞的关键因素,同时也是疫苗设计与宿主中和抗体生成的核心靶点。